PuSH - Publikationsserver des Helmholtz Zentrums München

Rauch, A.* ; Wieczorek, D.* ; Graf, E. ; Wieland, T. ; Endele, S.* ; Schwarzmayr, T. ; Albrecht, B.* ; Bartholdi, D.* ; Beygo, J.* ; di Donato, N.* ; Dufke, A.* ; Cremer, K.* ; Hempel, M.* ; Horn, D.* ; Hoyer, J.* ; Joset, P.* ; Ropke, A.* ; Moog, U.* ; Riess, A.* ; Thiel, C.T.* ; Tzschach, A.* ; Wiesener, A.* ; Wohlleber, E.* ; Zweier, C.* ; Ekici, A.B.* ; Zink, A.M.* ; Rump, A.* ; Meisinger, C. ; Grallert, H. ; Sticht, H.* ; Schenck, A.* ; Engels, H.* ; Rappold, G.* ; Schrock, E.* ; Wieacker, P.* ; Riess, O.* ; Meitinger, T. ; Reis, A.* ; Strom, T.M.

Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study.

Lancet 380, 1674-1682 (2012)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Background The genetic cause of intellectual disability in most patients is unclear because of the absence of morphological clues, information about the position of such genes, and suitable screening methods. Our aim was to identify de-novo variants in individuals with sporadic non-syndromic intellectual disability. Methods In this study, we enrolled children with intellectual disability and their parents from ten centres in Germany and Switzerland. We compared exome sequences between patients and their parents to identify de-novo variants. 20 children and their parents from the KORA Augsburg Diabetes Family Study were investigated as controls. Findings We enrolled 51 participants from the German Mental Retardation Network. 45 (88%) participants in the case group and 14 (70%) in the control group had de-novo variants. We identified 87 de-novo variants in the case group, with an exomic mutation rate of 1.71 per individual per generation. In the control group we identifi ed 24 de-novo variants, which is 1.2 events per individual per generation. More participants in the case group had loss-of-function variants than in the control group (20/51 vs 2/20; p=0.022), suggesting their contribution to disease development. 16 patients carried de-novo variants in known intellectual disability genes with three recurrently mutated genes (STXBP1, SYNGAP1, and SCN2A). We deemed at least six loss-of-function mutations in six novel genes to be disease causing. We also identifi ed several missense alterations with potential pathogenicity. Interpretation After exclusion of copy-number variants, de-novo point mutations and small indels are associated with severe, sporadic non-syndromic intellectual disability, accounting for 45-55% of patients with high locus heterogeneity. Autosomal recessive inheritance seems to contribute little in the outbred population investigated. The large number of de-novo variants in known intellectual disability genes is only partially attributable to known non-specific phenotypes. Several patients did not meet the expected syndromic manifestation, suggesting a strong bias in present clinical syndrome descriptions.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter De-novo Mutations ; Autism Spectrum Disorders ; Mental-retardation ; Developmental Delay ; Nonsense Mutation ; Delineation ; Variants ; Epilepsy ; Receptor ; Patient
ISSN (print) / ISBN 0140-6736
e-ISSN 0099-5355
Zeitschrift Lancet, The
Quellenangaben Band: 380, Heft: 9854, Seiten: 1674-1682 Artikelnummer: , Supplement: ,
Verlag Elsevier
Begutachtungsstatus Peer reviewed